Moreover, in a GReek AntiPlatElet registry substudy, DAPT with newer P2Y12 antagonists, but not clopidogrel, attenuated the negative impact of diabetes on ischemic CV events after ACS [9]. The gene discussed is P2RY12; the disease is diabetes mellitus.